{
    "paper_id": "PMC7241732",
    "metadata": {
        "title": "Rapid Detection of IgM Antibodies against the SARS-CoV-2 Virus via Colloidal\nGold Nanoparticle-Based Lateral-Flow Assay",
        "authors": [
            {
                "first": "Chao",
                "middle": [],
                "last": "Huang",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Tian",
                "middle": [],
                "last": "Wen",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Feng-Juan",
                "middle": [],
                "last": "Shi",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Xiao-Yan",
                "middle": [],
                "last": "Zeng",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Yong-Jun",
                "middle": [],
                "last": "Jiao",
                "suffix": "",
                "email": null,
                "affiliation": {}
            }
        ]
    },
    "body_text": [
        {
            "text": "In December 2019, the first pneumonia case of unknown etiological origins was reported in\nWuhan city, China, and then, a series of similar cases emerged with the clinical symptoms of\nviral pneumonia.1 Subsequently, high-throughput sequencing confirmed a\nnovel coronavirus to be the causative pathogen, which is currently named 2019 novel\ncoronavirus (SARS-CoV-2).2 Coronaviruses, such as SARS-CoV in\n20033\u22126 and\nMERS-CoV in 2012,7 have infected humans several times and led to serious\nconsequences in the past. Similarly, the infection of SARS-CoV-2 caused COVID-19. Because of\nthe severe human-to-human transmission, the disease quickly spread all around China and\nalmost the whole world and has become a globe public health emergency, as declared by the\nWHO.8",
            "cite_spans": [
                {
                    "start": 199,
                    "end": 200,
                    "mention": "1",
                    "ref_id": "BIBREF0"
                },
                {
                    "start": 363,
                    "end": 364,
                    "mention": "2",
                    "ref_id": "BIBREF11"
                },
                {
                    "start": 404,
                    "end": 405,
                    "mention": "3",
                    "ref_id": "BIBREF22"
                },
                {
                    "start": 406,
                    "end": 407,
                    "mention": "6",
                    "ref_id": "BIBREF43"
                },
                {
                    "start": 429,
                    "end": 430,
                    "mention": "7",
                    "ref_id": "BIBREF44"
                },
                {
                    "start": 760,
                    "end": 761,
                    "mention": "8",
                    "ref_id": "BIBREF45"
                }
            ],
            "section": "Introduction",
            "ref_spans": []
        },
        {
            "text": "Although COVID-19 could cause severe lung damage and lead to patient\u2019s death, this\ndisease also has many common clinical manifestations including fever, cough, myalgia,\nshortness of breath, and fatigue, and these symptoms are usually associated with other\nrespiratory infections.9 According to the guideline for COVID-19\ndiagnosis and treatment, real-time polymerase chain reaction (RT-PCR) is the predominant and\nstandard method for laboratory diagnosis.10 However, this method could\nnot overcome some non-negligible drawbacks, including the long nucleic acid extraction\nprocedure and nonsuitability for on-site detection. Also, false-negative results were\nunavoidable because of many factors, such as unstable reagents, low viral load in the\nsample, and improper sampling techniques.11\u221214 More importantly, as a sophisticated detection\nmethod, RT-PCR relies more on operators\u2019 experiences and complex equipments, and the\nrelative reagents need a cold chain support for both transportation and storage. All these\nfactors will delay the detection efficiency. Hence, it is urgently needed to establish a\nrapid and easily performed method to facilitate the on-site diagnosis of COVID-19.",
            "cite_spans": [
                {
                    "start": 279,
                    "end": 280,
                    "mention": "9",
                    "ref_id": "BIBREF46"
                },
                {
                    "start": 455,
                    "end": 457,
                    "mention": "10",
                    "ref_id": "BIBREF1"
                },
                {
                    "start": 785,
                    "end": 787,
                    "mention": "11",
                    "ref_id": "BIBREF2"
                },
                {
                    "start": 788,
                    "end": 790,
                    "mention": "14",
                    "ref_id": "BIBREF5"
                }
            ],
            "section": "Introduction",
            "ref_spans": []
        },
        {
            "text": "In addition to detecting the virus that COVID-19 patients carried, testing specific\nantibodies in serum is an alternative way to confirm SARS-CoV-2 infection, which was\naddressed by COVID-19 diagnosis and treatment guideline in China. For infectious diseases,\nthe IgM amount in blood increases rapidly during the acute infection phase, whether the\ninfected persons show clinical symptoms or not.15 For example, IgM\nagainst the SARS virus could be detected in blood samples several days after the infection\nhappened,16,17 while\nasymptomatic Zika virus carriers still have IgM antibody in their blood.18 For the above-mentioned reasons, developing a rapid detection method for IgM against\nSARS-CoV-2 will provide a valuable supplementary in the diagnosis of COVID-19.",
            "cite_spans": [
                {
                    "start": 395,
                    "end": 397,
                    "mention": "15",
                    "ref_id": "BIBREF6"
                },
                {
                    "start": 515,
                    "end": 517,
                    "mention": "16",
                    "ref_id": "BIBREF7"
                },
                {
                    "start": 518,
                    "end": 520,
                    "mention": "17",
                    "ref_id": "BIBREF8"
                },
                {
                    "start": 599,
                    "end": 601,
                    "mention": "18",
                    "ref_id": "BIBREF9"
                }
            ],
            "section": "Introduction",
            "ref_spans": []
        },
        {
            "text": "Because of their several advantages, such as easy operation, low cost, real-time result\nfeedback, and being independent of cold chain, rapid diagnosis strips are widely used in\nmany point-of-care testing (POCT) applications.19,20 Until now, a variety of signal reporters have been\nutilized, including colloidal gold nanoparticles,21 magnetic\nnanoparticles,22 upconverting nanoparticles,23\nquantum dots,24 and fluorescein isothiocyanates.25\nPOCT strips were mainly used in rapid detection of pregnancy and drug abuse during the early\nstage26,27 and many\nkinds of infectious diseases recently.28,29 The AuNP-LF assay is a rapidly developing technology, which\nutilizes colloidal gold nanoparticles, an easily synthesized and low-cost inorganic\nnanomaterials, as the reporter in immunoreactions.30 In contrast with\nother reporting labels, AuNPs were considered to possess unique advantages of long-term\nstability, obvious eye-reading results, easy operation, and free of complex instruments.\nFurthermore, AuNPs exhibit excellent biocompatibility and little biological\ntoxicity,31\u221233 which is a great advantage\nin in vitro and in vivo diagnosis. Therefore, the POCT\nstrip based on AuNP-LF assay is efficient for rapid on-site and low-cost detection because\nit gives easily observable positive or negative results. Until now, the AuNP-LF assay has\nbeen widely used to detect various analytes including infectious virus, proteins, drugs, and\nother pathogens.34\u221237",
            "cite_spans": [
                {
                    "start": 224,
                    "end": 226,
                    "mention": "19",
                    "ref_id": "BIBREF10"
                },
                {
                    "start": 227,
                    "end": 229,
                    "mention": "20",
                    "ref_id": "BIBREF12"
                },
                {
                    "start": 330,
                    "end": 332,
                    "mention": "21",
                    "ref_id": "BIBREF13"
                },
                {
                    "start": 356,
                    "end": 358,
                    "mention": "22",
                    "ref_id": "BIBREF14"
                },
                {
                    "start": 386,
                    "end": 388,
                    "mention": "23",
                    "ref_id": "BIBREF15"
                },
                {
                    "start": 402,
                    "end": 404,
                    "mention": "24",
                    "ref_id": "BIBREF16"
                },
                {
                    "start": 437,
                    "end": 439,
                    "mention": "25",
                    "ref_id": "BIBREF17"
                },
                {
                    "start": 538,
                    "end": 540,
                    "mention": "26",
                    "ref_id": "BIBREF18"
                },
                {
                    "start": 541,
                    "end": 543,
                    "mention": "27",
                    "ref_id": "BIBREF19"
                },
                {
                    "start": 591,
                    "end": 593,
                    "mention": "28",
                    "ref_id": "BIBREF20"
                },
                {
                    "start": 594,
                    "end": 596,
                    "mention": "29",
                    "ref_id": "BIBREF21"
                },
                {
                    "start": 791,
                    "end": 793,
                    "mention": "30",
                    "ref_id": "BIBREF23"
                },
                {
                    "start": 1073,
                    "end": 1075,
                    "mention": "31",
                    "ref_id": "BIBREF24"
                },
                {
                    "start": 1076,
                    "end": 1078,
                    "mention": "33",
                    "ref_id": "BIBREF26"
                },
                {
                    "start": 1451,
                    "end": 1453,
                    "mention": "34",
                    "ref_id": "BIBREF27"
                },
                {
                    "start": 1454,
                    "end": 1456,
                    "mention": "37",
                    "ref_id": "BIBREF30"
                }
            ],
            "section": "Introduction",
            "ref_spans": []
        },
        {
            "text": "In this article, a rapid detection method for the IgM antibody against the SARS-CoV-2\nvirus, using the SARS-CoV-2 NP prepared by our group as the capture antigen, was designed\nand developed. This Au NP-LF assay combines the merits of the immune lateral-flow system and\nunique properties of AuNPs and is easily operated and cost-effective in large-scale\ndetection. Especially, the whole test process lasts for less than 15 min to obtain results\nand requires only 10\u201320 \u03bcL serum. We discussed several factors in the\npreparation of colloidal gold immune conjugates and the manufacture of AuNP-LF strips. The\nsensitivity, specificity, and stability were evaluated by testing clinical positive and\nnegative serum samples, with RT-PCR\u2019s test results as the control. Considering all\nthe advantages of this newly developed AuNP-LF assay, it is possible for it to become an\nauxiliary diagnostic method for COVID-19 and has great potential in containing worldwide\npandemic.",
            "cite_spans": [],
            "section": "Introduction",
            "ref_spans": []
        },
        {
            "text": "UV\u2013vis absorption spectra of AuNPs are shown in Figure 1A, and the maximum ultraviolet absorption peak of AuNPs was located\nat 525 nm, which was coincident with the theoretical equation reported previously.38 The obtained AuNPs have good distribution uniformity in the aqueous\nsolution, which could be indicated from the narrow peak shape of UV\u2013vis absorption\nspectra. As shown in Figure 1B, the transmission\nelectron microscopy (TEM) image showed that AuNPs were about 30 nm in diameter. AuNPs of\nthis size were suitable for conjugating proteins as the previous literature\ndescribed.39",
            "cite_spans": [
                {
                    "start": 206,
                    "end": 208,
                    "mention": "38",
                    "ref_id": "BIBREF31"
                },
                {
                    "start": 584,
                    "end": 586,
                    "mention": "39",
                    "ref_id": "BIBREF32"
                }
            ],
            "section": "Characterization of AuNPs ::: Results and Discussion",
            "ref_spans": [
                {
                    "start": 48,
                    "end": 56,
                    "mention": "Figure 1",
                    "ref_id": "FIGREF0"
                },
                {
                    "start": 381,
                    "end": 389,
                    "mention": "Figure 1",
                    "ref_id": "FIGREF0"
                }
            ]
        },
        {
            "text": "As we know, when the reaction system\u2019s pH value is close or a little higher than\nthe isoelectric point of the antibody, the electrostatic and physical adsorption between\nAuNPs and antibodies are most stable.40,41 High concentration of salt will bring destructive effect\ninto the reaction system. Figure S2A displayed that the reaction system\u2019s color under the\noptimal pH remained wine-red, while those under other pH changed to purple or even white.\nHence, the optimal pH value was determined to be 8.0. Similarly, as shown in Figure S2B, 1.5 \u03bcg of anti-human IgM was sufficient to stabilize the\nconjugate. According to the previous literature,42 1.8 \u03bcg of\nanti-human IgM, slightly more than the above-mentioned antibody amount, was selected as\nthe optimal level.",
            "cite_spans": [
                {
                    "start": 207,
                    "end": 209,
                    "mention": "40",
                    "ref_id": "BIBREF34"
                },
                {
                    "start": 210,
                    "end": 212,
                    "mention": "41",
                    "ref_id": "BIBREF35"
                },
                {
                    "start": 644,
                    "end": 646,
                    "mention": "42",
                    "ref_id": "BIBREF36"
                }
            ],
            "section": "Optimization of AuNP\u2013(Anti-Human IgM) Conjugates ::: Results and Discussion",
            "ref_spans": []
        },
        {
            "text": "The test performance of AuNP-LF mainly depended on several elements, such as protein\ncoating concentration and nitrocellulose membrane block effects. Figure\n2A showed the test results using different SARS-CoV-2 NP\nconcentration (0.3, 0.6, 1.0, 1.2 mg/mL) coated on the test line (T line). When the\nCOVID-19 positive serum sample was tested, the color intensity of the T line was most\nsignificant with 1.2 mg/mL SARS-CoV-2 NP, but the flatness of the T line was not as good\nas 1.0 mg/mL SARS-CoV-2 NP. At lower concentrations, for example, 0.6 and 0.3 mg/mL, the\nred T line was difficult to be observed by naked eyes, so the optimal SARS-CoV-2 NP\nconcentration was selected to be 1.0 mg/mL. Similarly, when normal persons\u2019 sera\nwere tested, various concentrations of goat\u2013anti-mouse IgG (0.5, 1.0, 2.0, 3.0\nmg/mL) coated on the control line (C line) resulted in different visual effects (Figure 2B). Considering the intensity of the C line\nand antibody usage amount, 2.0 mg/mL goat\u2013anti-mouse IgG was chosen for C line\ncoating.",
            "cite_spans": [],
            "section": "AuNP-LF Performance ::: Results and Discussion",
            "ref_spans": [
                {
                    "start": 150,
                    "end": 158,
                    "mention": "Figure\n2",
                    "ref_id": "FIGREF1"
                },
                {
                    "start": 887,
                    "end": 895,
                    "mention": "Figure 2",
                    "ref_id": "FIGREF1"
                }
            ]
        },
        {
            "text": "Another factor that had an impact on the performance of the AuNP-LF assay was the\nnitrocellulose membrane block effects. Different concentrations of bovine serum albumin\n(BSA) were blocked on the nitrocellulose membrane to reduce nonspecific adsorption. When\nnormal human sera were tested, strips with 1.0 and 2.0 mg/mL BSA blocking did not show any\nT line signal, while the other two strips (0 and 0.5 mg/mL BSA blocking) showed false\npositives (Figure 3). For positive samples, all\nstrips exhibited a visible red T line, while the strip with 2 mg/mL BSA blocking showed a\npretty weak one. This indicated that excessive BSA would reduce AuNP-LF\u2019s\nsensitivity. From the above, we selected 1.0 mg/mL BSA to block the nitrocellulose\nmembrane in order to eliminate nonspecific binding.",
            "cite_spans": [],
            "section": "AuNP-LF Performance ::: Results and Discussion",
            "ref_spans": [
                {
                    "start": 447,
                    "end": 455,
                    "mention": "Figure 3",
                    "ref_id": "FIGREF2"
                }
            ]
        },
        {
            "text": "To study the performance of the AuNP-LF assay, the sensitivity of the test is also of\nsignificant importance. Nevertheless, when detecting antibodies using the\nimmunochromatography method, the hook effect could not be neglected.43\nThe hook effect results from the coinstantaneous reaction of an excess target protein with\nboth immobilized and labeled antibodies or antigens. In this designed AuNP-LF assay, a\nlarger amount of sera did not mean certain better sensitivity. A suitable proportion of\nserum and sample treating buffer took a significant role in improving the performance of\nthe AuNP-LF assay. Different results were shown in Table S1. When 20 \u03bcL of the serum sample and 80 \u03bcL of treating\nbuffer were mixed and tested, the result was much reliable than other conditions. For\nexample, reducing serum to less than 10 \u03bcL might lead to incomplete absorption and\nresult in misdetection. Conversely, excess serum had the chance to introduce a false\npositive phenomenon.",
            "cite_spans": [
                {
                    "start": 228,
                    "end": 230,
                    "mention": "43",
                    "ref_id": "BIBREF37"
                }
            ],
            "section": "AuNP-LF Performance ::: Results and Discussion",
            "ref_spans": []
        },
        {
            "text": "Specificity is a key indicator in preventing the false-positive phenomenon from\ncross-reaction. One positive SARS-CoV-2 serum, two SFTSV sera, two DFV sera, and one\nnormal human serum were tested using AuNP-LF strips. As shown in Figure\n4, only the SARS-CoV-2 strip displayed a legible red T line\nsignal, while other strips showed no visible T lines. These results meant that there was\nnot any cross-reactivity between SARS-CoV-2 and other listed viruses, which indicated the\nAuNP-LF\u2019s excellent specificity.",
            "cite_spans": [],
            "section": "Specificity of the AuNP-LF Assay ::: Results and Discussion",
            "ref_spans": [
                {
                    "start": 230,
                    "end": 238,
                    "mention": "Figure\n4",
                    "ref_id": "FIGREF3"
                }
            ]
        },
        {
            "text": "The stability and reproducibility are of great practical value in POCT strips. Observed\nby naked eyes, the color depth at the T line revealed almost no differences at continuous\ndetecting time points (1, 2, and 4 weeks) when SARS-CoV-2 samples were tested with SFTSV,\nDFV, and normal human serum samples as the control (Figure 5). Each sample was tested consecutive for ten times. This result\ndemonstrated that our developed AuNP-LF assay possesses satisfactory stability.",
            "cite_spans": [],
            "section": "Stability and Reproducibility of the AuNP-LF Assay ::: Results and Discussion",
            "ref_spans": [
                {
                    "start": 320,
                    "end": 328,
                    "mention": "Figure 5",
                    "ref_id": "FIGREF4"
                }
            ]
        },
        {
            "text": "The final purpose of the work was to establish a rapid and reliable method to detect the\nIgM antibody against the SARS-CoV-2 virus in COVID-19 patients\u2019 serum directly by\nnaked eyes. In order to evaluate AuNP-LF\u2019s practicality, serum samples from five\npatients infected by SARS-CoV-2 (confirmed by RT-PCR) were collected and tested using our\nprepared strips, while normal humans\u2019 serum samples were assessed as the control.\nAs shown in Figure S3 and Table 1, five\nRT-PCR-confirmed serum samples were all determined to be seropositive by AuNP-LF strips.\nMeanwhile, 13 out of 14 normal humans\u2019 sera were detected to be negative by our\nAuNP-LF assay, and only one sample was tested to be positive. Comprehensively analyzing\nthe test results of the RT-PCR and AuNP-LF assay, our strips had a good consistency by the\nKappa test (\u03ba coefficient = 0.872). The sensitivity and specificity of AuNP-LF were\n100 and 93.3%, respectively, and the Youden index was 0.933. All the analysis indicators\ndemonstrate that our designed unique AuNP-LF assay is suitable for rapid and on-site\nsurveillance of SARS-CoV-2 infection.",
            "cite_spans": [],
            "section": "Analysis Performance of the AuNP-LF Assay ::: Results and Discussion",
            "ref_spans": []
        },
        {
            "text": "All the results described above indicated that our designed AuNP-LF assay should have\ngreat significance in detecting the IgM antibody against the SARS-CoV-2 virus. In\ncomparison with other traditional methods, the AuNP-LF assay exhibits several advantages\nas follows. First, AuNPs, employed to generate a test signal in the immunological\ntechnique, were stable and hard to be deactivated. Second, the sample consumption for each\ntest was only 10\u201320 \u03bcL, while the nucleic acid extraction process of the\nRT-PCR usually required more than 100 \u03bcL of the sample. In addition to less sample\nusage, the total test time could be controlled within 15 min, while other test methods\nusually needed several hours. Furthermore, our designed AuNP-LF assay is particularly easy\nto practise, and the operators only need a minimal training, which means that tests could\nbe carried out in any place, including primary hospitals and remote regions, as these\nfacilities are usually lack sophisticated detection equipment and professional\ntechnicians. Meanwhile, the materials involved in assembling AuNP-LF strips, including\ncolloidal gold nanoparticles, have excellent biocompatibility and biosecurity. In\naddition, the AuNP-LF assay does not need any instrument, and all the reagents and\nmaterials used in preparing strips are at a very low cost. Moreover, the AuNP-LF assay\ncould avoid collecting patients\u2019 respiratory tract specimen, so the health-care\nworkers\u2019 risk of getting infected could be significantly reduced.",
            "cite_spans": [],
            "section": "Analysis Performance of the AuNP-LF Assay ::: Results and Discussion",
            "ref_spans": []
        },
        {
            "text": "To sum up, we have fabricated AuNP-LF strips for rapid and on-site detection of the IgM\nantibody against the SARS-CoV-2 virus. In order to make the diagnosis of COVID-19 more\naccurate and reasonable, molecular and serological investigation should be applied\nsimultaneously,44,45\nsuch as the widely used RT-PCR test and our designed AuNP-LF assay. In our developed POCT\nstrips, AuNPs\u2019 unique features, such as excellent stability and simple synthesis, and\nthe specific binding force between the matched antigen and antibody, were appropriately\ncombined. Compared with the primarily used RT-PCR method, the AuNP-LF assay exhibits several\nsuperiorities including quick test time, less sample consumption, simplicity of operation,\ndispensing with expensive instruments, independence of professional experience, and much\nlower cost of each test. Also, as a reliable immunological detection, this proposed AuNP-LF\nassay has favorable specificity and repeatability. We tested both positive and negative\nSARS-CoV-2 serum samples, the result of the AuNP-LF assay has a good consistency with that\nof RT-PCR. As research continues, the newly developed method should have great potential in\nlarge-scale and fast detection, especially for urgent conditions, and will surely become an\nimportant supplementary diagnosis method for COVID-19.",
            "cite_spans": [
                {
                    "start": 273,
                    "end": 275,
                    "mention": "44",
                    "ref_id": "BIBREF38"
                },
                {
                    "start": 276,
                    "end": 278,
                    "mention": "45",
                    "ref_id": "BIBREF39"
                }
            ],
            "section": "Conclusions",
            "ref_spans": []
        },
        {
            "text": "Chloroauric acid hydrated (HAuCl4) and sodium citrate were purchased from\nSigma-Aldrich (StLouis, MO, USA). Nitrocellulose membranes, glass fibers, absorbent\npapers, plastic cartridges for strips, goat antimouse IgG, and antihuman IgM were\npurchased from Shanghai JieYi Biotechnology Co.Ltd. (Shanghai, China). The SARS-CoV-2 NP\nwas prepared and purified by our own research group. Serum samples of COVID-19 patients\nand normal human were obtained from the Jiangsu Provincial Center for Disease Prevention\nand Control. Other reagents are analytical pure and purchased from Sinopharm Chemical\nReagent Co., Ltd (Shanghai, China). Ultrapure water used during the experiment was\nproduced using a Millipore Milli-Q water purification system (Billerica. MA, USA).",
            "cite_spans": [],
            "section": "Materials and Chemicals ::: Materials and Methods",
            "ref_spans": []
        },
        {
            "text": "AuNPs of size \u2248 30 nm were fabricated according to the classical method with\nproper modifications,46 and the specific steps of the synthesis process\nare described in the Supporting Information. A JEM-2100 transmission electron microscope (JEOL\nLtd.) was used to measure the diameter and morphology of AuNPs, and the UV\u2013vis\nabsorption spectra of AuNPs were obtained using a Shimadzu UV-2600 spectrophotometer\n(Tokyo, Japan). All the photos in this article were taken with a digital camera by the\nauthors.",
            "cite_spans": [
                {
                    "start": 98,
                    "end": 100,
                    "mention": "46",
                    "ref_id": "BIBREF40"
                }
            ],
            "section": "Synthesis and Characterization of AuNPs ::: Materials and Methods",
            "ref_spans": []
        },
        {
            "text": "The recombinant SARS-CoV-2 NP was expressed and purified using the method that our group\ndeveloped in other protein\u2019s production.47 The detailed process\nwas presented in the Supporting Information. Sodium dodecyl sulfate\u2013polyacrylamide gel\nelectrophoresis (SDS\u2013PAGE) was applied to analyze the purified protein, and the\nresult is shown in Figure S1. All operations were performed following the manufacturer\u2019s\ninstructions.",
            "cite_spans": [
                {
                    "start": 129,
                    "end": 131,
                    "mention": "47",
                    "ref_id": "BIBREF41"
                }
            ],
            "section": "Cloning and Expression of the SARS-CoV-2 NP ::: Materials and Methods",
            "ref_spans": []
        },
        {
            "text": "SARS-CoV-2-positive and -negative serum samples were applied in this study. All the sera\nwere collected in Jiangsu province, China. Moreover, SFTSV and DFV sera were also\ncollected for specificity evaluation.",
            "cite_spans": [],
            "section": "Collection of Serum Samples ::: Materials and Methods",
            "ref_spans": []
        },
        {
            "text": "Before preparing the AuNP\u2013(anti-human IgM) conjugate, the reaction condition\nincluding the pH value and antibody concentration, should be optimized. First, each\ncentrifuge tube was filled with 200 \u03bcL of AuNP solution. The reaction system was\nadjusted to series of pH (6.5, 7.0, 7.5, 8.0, 8.5, 9.0, 9.5, and 10.0). Then, the labeled\nantibody was added into the mixture followed by a 10 min incubation at room temperature.\nSubsequently, 45 \u03bcL of 10% NaCl was added into the reaction system, and the mixture\nwas incubated for another 2 h. Finally, the mixture\u2019s color changing was observed.\nAnalogously, the optimization of the labeled antibody was studied by adding different\namounts of antihuman IgM (0, 0.75, 1.5, 3.0, 4.5, 6.0, and 7.5 \u03bcg) into the reaction\nsystem. Under the optimal pH value and antibody amount, antihuman IgM was conjugated to\nthe surface of AuNPs to form AuNP\u2013(anti-human IgM) bioconjugates. First, 1 mL of\nAuNP solution was adjusted to the optimal pH, and then, 9 \u03bcg of anti-human IgM was\nadded into the mixture and stirred for 30 min. Next, 250 \u03bcL of 5% (w/v) BSA solution\nwas added to the reaction system with another 30 min stirring for blocking. Afterward, the\nproducts were collected by a two-step centrifugation. First, the solution was centrifuged\nat 2000 rpm for 10 min, and the impurity of large and inhomogenous particles were\ndiscarded. Second, the remained supernatant was centrifuged again at 13,200 rpm for\nanother 10 min, and the sediment was kept. Finally, 500 \u03bcL of resuspension buffer\n[containing 0.5% (w/v) BSA, 0.5% (v/v) Tween-20, 2% (w/v) sucrose and 50 mM Tris] was used\nto resuspend the sediment products, and the AuNP\u2013(anti-human IgM) conjugates were\nobtained.",
            "cite_spans": [],
            "section": "Conjugation of Antihuman IgM to AuNPs ::: Materials and Methods",
            "ref_spans": []
        },
        {
            "text": "The AuNP-LF strip is composed of a sample pad (10 \u00d7 4 mm), a conjugate pad (8 \u00d7\n4 mm), a nitrocellulose membrane (20 \u00d7 4 mm), and an absorbent pad (10 \u00d7 4 mm).\nAll these components are attached to a PVC backing card. The schematic diagram of the test\nstrip is presented in Scheme 1.\nAuNP\u2013(anti-human IgM) conjugates were immobilized on the conjugate pad, and then,\nthe pad was dried at 37 \u00b0C for 1 h. The SARS-CoV-2 NP and goat antimouse IgG were\ndispensed on the nitrocellulose membrane at the concentration of 1.0 mg/mL for the T line\nand 2.0 mg/mL for the C line with the two lines\u2019 interval at 4 mm, and then, the\nnitrocellulose membrane was blocked using 1% (w/v) BSA for 30 min and dried at 37 \u00b0C\nfor 2 h. Finally, the prepared strip was assembled into a plastic shell and stored in a\nvacuum bag for future use. During the manufacture process, one piece of the nitrocellulose\nmembrane could produce at least 75 strips, so each strip was very cost-effective.",
            "cite_spans": [],
            "section": "Development of AuNP-LF Strips ::: Materials and Methods",
            "ref_spans": []
        },
        {
            "text": "For detection, serum and sample treating buffer [30 mM PBS, pH 7.4, containing 1% (w/v)\nBSA, 0.1% (v/v) Triton X-100] were mixed at the desired ratio of 1:4, and then, 100\n\u03bcL of the mixture was added onto the sample port of the AuNP-LF strip; then, the\nliquid transferred toward the absorbent pad under the hydrodynamic force and capillary\npower. During the test procedure, IgM in serum could be captured by the\nAuNP\u2013(anti-human IgM) conjugate at the conjugate pad, and then, the\nAuNP\u2013(anti-human IgM)\u2013IgM compound flowed to the analytical membrane. The\nSARS-CoV-2 NP immobilized at the T line caught the target IgM against SARS-CoV-2 and form\nthe AuNP\u2013(anti-human IgM)\u2013(SARS-CoV-2 IgM)\u2013(SARS-CoV-2 NP) compound,\nwhile goat antimouse IgG immobilized at the C line directly caught AuNP\u2013(anti-human\nIgM) and form the AuNP\u2013(anti-human IgM)\u2013(goat-anti mouse IgG) compound. The\npositive and negative results could be determined by the specific reddish-purple tracer of\nAuNPs. The red C line represents the strip\u2019s effectivity. If there was not a\nvisible C line, whether a red T line appeared or not, the test result should be judged as\ninvalid (Scheme 2). The detecting results could\nbe easily judged by naked eyes within 15 min.",
            "cite_spans": [],
            "section": "AuNPs-LF Assay Procedures ::: Materials and Methods",
            "ref_spans": []
        },
        {
            "text": "Serum samples of several different diseases caused by other viruses were employed to\nstudy the specificity of the AuNP-LF assay, including SFTSV and DFV. The AuNP-LF strips\nused in this test belong to the same batch. Also, serum samples mentioned above were used\nto evaluate the stability of AuNP-LF strips. The strips were stored in cool, dry,\nairproof, and nonpollutuded conditions for different periods (1, 2, and 4 weeks). The test\nresult was determined by the intensity of the T line which can easily be observed by the\nnaked eyes.",
            "cite_spans": [],
            "section": "Specificity and Stability of the AuNP-LF Assay ::: Materials and Methods",
            "ref_spans": []
        },
        {
            "text": "Clinical specimens, including serum of clinically confirmed COVID-19 patients (positive)\nand normal humans (negative), were applied for the AuNP-LF assay, using RT-PCR as the\ncontrast method. The consistency of the two methods was checked using the Kappa test.",
            "cite_spans": [],
            "section": "Clinical Serum Samples Detection ::: Materials and Methods",
            "ref_spans": []
        }
    ],
    "ref_entries": {
        "FIGREF0": {
            "text": "Figure 1: (A) TEM image of AuNPs. (B) UV\u2013vis spectra of AuNPs.",
            "type": "figure"
        },
        "FIGREF1": {
            "text": "Figure 2: Performance of AuNP-LF based on different concentrations of (A) SARS-CoV-2 NP and (B)\ngoat\u2013anti-mouse IgG.",
            "type": "figure"
        },
        "FIGREF2": {
            "text": "Figure 3: AuNP-LF performance based on nitrocellulose membrane block effects.",
            "type": "figure"
        },
        "FIGREF3": {
            "text": "Figure 4: Specificity of AuNP-LF strips.",
            "type": "figure"
        },
        "FIGREF4": {
            "text": "Figure 5: Stability of AuNP-LF strips.",
            "type": "figure"
        }
    },
    "back_matter": [],
    "bib_entries": {
        "BIBREF0": {
            "title": "Outbreak of Pneumonia of Unknown Etiology in Wuhan China: the Mystery and\nthe Miracle",
            "authors": [],
            "year": 2020,
            "venue": "J. Med. Virol.",
            "volume": "92",
            "issn": "",
            "pages": "401-402",
            "other_ids": {
                "DOI": [
                    "10.1002/jmv.25678"
                ]
            }
        },
        "BIBREF1": {
            "title": "A rapid advice guideline for the diagnosis and treatment of 2019 novel\ncoronavirus (COVID-19) infected pneumonia (standard version)",
            "authors": [],
            "year": 2020,
            "venue": "Mil. Med. Res.",
            "volume": "7",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1186/s40779-020-0233-6"
                ]
            }
        },
        "BIBREF2": {
            "title": "False negative results from using common PCR reagents",
            "authors": [],
            "year": 2011,
            "venue": "BMC Res. Notes",
            "volume": "4",
            "issn": "",
            "pages": "457-463",
            "other_ids": {
                "DOI": [
                    "10.1186/1756-0500-4-457"
                ]
            }
        },
        "BIBREF3": {
            "title": "False-Negative Results of Real-Time Reverse-Transcriptase Polymerase Chain\nReaction for Severe Acute Respiratory Syndrome Coronavirus 2: Role of\nDeep-Learning-Based CT Diagnosis and Insights from Two Cases",
            "authors": [],
            "year": 2020,
            "venue": "Korean J. Radiol.",
            "volume": "21",
            "issn": "",
            "pages": "505-508",
            "other_ids": {
                "DOI": [
                    "10.3348/kjr.2020.0146"
                ]
            }
        },
        "BIBREF4": {
            "title": "Correlation of Chest CT and RT-PCR Testing in Coronavirus Disease 2019\n(COVID-19) in China: A Report of 1014 Cases",
            "authors": [],
            "year": 2020,
            "venue": "Radiology",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1148/radiol.2020200642"
                ]
            }
        },
        "BIBREF5": {
            "title": "Negative Nasopharyngeal and Oropharyngeal Swab Does Not Rule Out\nCOVID-19",
            "authors": [],
            "year": 2020,
            "venue": "J. Clin. Microbiol.",
            "volume": "58",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1128/JCM.00297-20"
                ]
            }
        },
        "BIBREF6": {
            "title": "IgM in human immunity to plasmodium falciparum malaria",
            "authors": [],
            "year": 2019,
            "venue": "Sci. Adv.",
            "volume": "5",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1126/sciadv.aax4489"
                ]
            }
        },
        "BIBREF7": {
            "title": "Production of specific antibodies against SARS-coronavirus nucleocapsid\nprotein without cross reactivity with human coronaviruses 229E and OC43",
            "authors": [],
            "year": 2010,
            "venue": "J. Vet. Sci.",
            "volume": "11",
            "issn": "",
            "pages": "165-167",
            "other_ids": {
                "DOI": [
                    "10.4142/jvs.2010.11.2.165"
                ]
            }
        },
        "BIBREF8": {
            "title": "The Detect ion and Trace of SARS Coronavirus Antibodies",
            "authors": [],
            "year": 2005,
            "venue": "J. Practical Med. Tech.",
            "volume": "12",
            "issn": "",
            "pages": "1380-1382",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF9": {
            "title": "Preconceptual Zika virus asymptomatic infection protects against secondary\nprenatal infection",
            "authors": [],
            "year": 2017,
            "venue": "PLoS Pathog.",
            "volume": "13",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1371/journal.ppat.1006684"
                ]
            }
        },
        "BIBREF10": {
            "title": "Lateral flow (immuno)assay: its strengths, weaknesses, opportunities and\nthreats. A literature survey",
            "authors": [],
            "year": 2009,
            "venue": "Anal. Bioanal. Chem.",
            "volume": "393",
            "issn": "",
            "pages": "569-582",
            "other_ids": {
                "DOI": [
                    "10.1007/s00216-008-2287-2"
                ]
            }
        },
        "BIBREF11": {
            "title": "A Novel Coronavirus from Patients with Pneumonia in China,\n2019",
            "authors": [],
            "year": 2020,
            "venue": "N. Engl. J. Med.",
            "volume": "382",
            "issn": "",
            "pages": "727-733",
            "other_ids": {
                "DOI": [
                    "10.1056/nejmoa2001017"
                ]
            }
        },
        "BIBREF12": {
            "title": "Lateral flow assays",
            "authors": [],
            "year": 2016,
            "venue": "Essays Biochem.",
            "volume": "60",
            "issn": "",
            "pages": "111-120",
            "other_ids": {
                "DOI": [
                    "10.1042/ebc20150012"
                ]
            }
        },
        "BIBREF13": {
            "title": "Rapid Detection of Severe Fever with Thrombocytopenia Syndrome Virus via\nColloidal Gold Immunochromatography Assay",
            "authors": [],
            "year": 2018,
            "venue": "ACS Omega",
            "volume": "3",
            "issn": "",
            "pages": "15399-15406",
            "other_ids": {
                "DOI": [
                    "10.1021/acsomega.8b02366"
                ]
            }
        },
        "BIBREF14": {
            "title": "Magnetic Fe3O4@TiO2 nanoparticles-based\ntest strip immunosensing device for rapid detection of phosphorylated\nbutyrylcholinesterase",
            "authors": [],
            "year": 2013,
            "venue": "Biosens. Bioelectron.",
            "volume": "50",
            "issn": "",
            "pages": "486-491",
            "other_ids": {
                "DOI": [
                    "10.1016/j.bios.2013.07.017"
                ]
            }
        },
        "BIBREF15": {
            "title": "Rapid detection of severe fever with thrombocytopeniasyndrome virus (SFTSV)\ntotal antibodies by up-converting phosphor technology-based lateral-flow\nassay",
            "authors": [],
            "year": 2019,
            "venue": "Luminescence",
            "volume": "34",
            "issn": "",
            "pages": "162-167",
            "other_ids": {
                "DOI": [
                    "10.1002/bio.3588"
                ]
            }
        },
        "BIBREF16": {
            "title": "Rapid detection of Shiga Toxin type II by lateral flow immunochromatography\ntest strips of colorimetry and fluorimetry",
            "authors": [],
            "year": 2019,
            "venue": "Analyst",
            "volume": "145",
            "issn": "",
            "pages": "76-82",
            "other_ids": {
                "DOI": [
                    "10.1039/c9an01996k"
                ]
            }
        },
        "BIBREF17": {
            "title": "Dual FITC lateral flow immunoassay for sensitive detection of Escherichia\ncoli O157:H7 in food samples",
            "authors": [],
            "year": 2016,
            "venue": "Biosens. Bioelectron.",
            "volume": "85",
            "issn": "",
            "pages": "734-739",
            "other_ids": {
                "DOI": [
                    "10.1016/j.bios.2016.05.057"
                ]
            }
        },
        "BIBREF18": {
            "title": "Automated low-cost smartphone-based lateral flow saliva test reader for\ndrugs-of-abuse detection",
            "authors": [],
            "year": 2015,
            "venue": "Sensors",
            "volume": "15",
            "issn": "",
            "pages": "29569-29593",
            "other_ids": {
                "DOI": [
                    "10.3390/s151129569"
                ]
            }
        },
        "BIBREF19": {
            "title": "Strips of Hope: Accuracy of Home Pregnancy Tests and New\nDevelopments",
            "authors": [],
            "year": 2014,
            "venue": "Geburtshilfe Frauenheilkd.",
            "volume": "74",
            "issn": "",
            "pages": "661-669",
            "other_ids": {
                "DOI": [
                    "10.1055/s-0034-1368589"
                ]
            }
        },
        "BIBREF20": {
            "title": "Dual recognition element lateral flow assay toward multiplex strain\nspecific influenza virus detection",
            "authors": [],
            "year": 2017,
            "venue": "Anal. Chem.",
            "volume": "89",
            "issn": "",
            "pages": "6781-6786",
            "other_ids": {
                "DOI": [
                    "10.1021/acs.analchem.7b01149"
                ]
            }
        },
        "BIBREF21": {
            "title": "A Serological Point-of-Care Test for the Detection of IgG Antibodies\nagainst Ebola Virus in Human Survivors",
            "authors": [],
            "year": 2018,
            "venue": "ACS Nano",
            "volume": "12",
            "issn": "",
            "pages": "63-73",
            "other_ids": {
                "DOI": [
                    "10.1021/acsnano.7b07021"
                ]
            }
        },
        "BIBREF22": {
            "title": "Epidemiology and cause of severe acute respiratory syndrome (SARS) in\nGuangdong, People\u2019s Republic of China, in February, 2003",
            "authors": [],
            "year": 2003,
            "venue": "Lancet",
            "volume": "362",
            "issn": "",
            "pages": "1353-1358",
            "other_ids": {
                "DOI": [
                    "10.1016/s0140-6736(03)14630-2"
                ]
            }
        },
        "BIBREF23": {
            "title": "Gold nanoparticle-based colorimetric biosensors",
            "authors": [],
            "year": 2018,
            "venue": "Nanoscale",
            "volume": "10",
            "issn": "",
            "pages": "18-33",
            "other_ids": {
                "DOI": [
                    "10.1039/c7nr06367a"
                ]
            }
        },
        "BIBREF24": {
            "title": "Gold nanoparticle-enabled biological and chemical detection and\nanalysis",
            "authors": [],
            "year": 2012,
            "venue": "Chem. Soc. Rev.",
            "volume": "41",
            "issn": "",
            "pages": "2849-2866",
            "other_ids": {
                "DOI": [
                    "10.1039/c1cs15280g"
                ]
            }
        },
        "BIBREF25": {
            "title": "Biomedical Applications of Gold Nanoparticles",
            "authors": [],
            "year": 2015,
            "venue": "Curr. Top. Med. Chem.",
            "volume": "15",
            "issn": "",
            "pages": "1605-1613",
            "other_ids": {
                "DOI": [
                    "10.2174/1568026615666150414144750"
                ]
            }
        },
        "BIBREF26": {
            "title": "Sensing colorimetric approaches based on gold and silver nanoparticles\naggregation: chemical creativity behind the assay. A review",
            "authors": [],
            "year": 2012,
            "venue": "Anal. Chim. Acta",
            "volume": "751",
            "issn": "",
            "pages": "24-43",
            "other_ids": {
                "DOI": [
                    "10.1016/j.aca.2012.08.043"
                ]
            }
        },
        "BIBREF27": {
            "title": "Development of a colloidal gold-based immunochromatographic strip test\nusing two monoclonal antibodies to detect H7N9 avian influenza virus",
            "authors": [],
            "year": 2020,
            "venue": "Virus Genes",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1007/s11262-020-01742-8"
                ]
            }
        },
        "BIBREF28": {
            "title": "Single-chain variable fragment antibody-based immunochromatographic strip\nfor rapid detection of fumonisin B1 in maize samples",
            "authors": [],
            "year": 2020,
            "venue": "Food Chem.",
            "volume": "319",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1016/j.foodchem.2020.126546"
                ]
            }
        },
        "BIBREF29": {
            "title": "A lateral flow assay for the determination of human tetanus antibody in\nwhole blood by using gold nanoparticle labeled tetanus antigen",
            "authors": [],
            "year": 2018,
            "venue": "Mikrochim. Acta",
            "volume": "185",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1007/s00604-017-2657-6"
                ]
            }
        },
        "BIBREF30": {
            "title": "Homogeneous and high-density gold unit implanted optical labels for robust\nand sensitive point-of-care drug detection",
            "authors": [],
            "year": 2019,
            "venue": "Nanoscale",
            "volume": "11",
            "issn": "",
            "pages": "16026-16035",
            "other_ids": {
                "DOI": [
                    "10.1039/c9nr03740c"
                ]
            }
        },
        "BIBREF31": {
            "title": "Determination of size and concentration of gold nanoparticles from UV-vis\nspectra",
            "authors": [],
            "year": 2007,
            "venue": "Anal. Chem.",
            "volume": "79",
            "issn": "",
            "pages": "4215-4221",
            "other_ids": {
                "DOI": [
                    "10.1021/ac0702084"
                ]
            }
        },
        "BIBREF32": {
            "title": "Preparation of Colloidal Gold Particles and Conjugation to Protein A, IgG,\nF(ab\u2019) 2, and Streptavidin",
            "authors": [],
            "year": 2010,
            "venue": "Methods Mol. Biol.",
            "volume": "657",
            "issn": "",
            "pages": "109-119",
            "other_ids": {
                "DOI": [
                    "10.1007/978-1-60761-783-9_8"
                ]
            }
        },
        "BIBREF33": {
            "title": "A novel coronavirus associated with severe acute respiratory\nsyndrome",
            "authors": [],
            "year": 2003,
            "venue": "N. Engl. J. Med.",
            "volume": "348",
            "issn": "",
            "pages": "1953-1966",
            "other_ids": {
                "DOI": [
                    "10.1056/nejmoa030781"
                ]
            }
        },
        "BIBREF34": {
            "title": "Development of a high-performance immunolatex based on \u201csoft\nlanding\u201d antibody immobilization mechanism",
            "authors": [],
            "year": 2012,
            "venue": "Colloids Surf., B",
            "volume": "99",
            "issn": "",
            "pages": "45-52",
            "other_ids": {
                "DOI": [
                    "10.1016/j.colsurfb.2011.09.040"
                ]
            }
        },
        "BIBREF35": {
            "title": "Ultrastructural localization of intracellular antigens by the use of\nprotein A-gold complex",
            "authors": [],
            "year": 1978,
            "venue": "J. Histochem. Cytochem.",
            "volume": "26",
            "issn": "",
            "pages": "1074-1081",
            "other_ids": {
                "DOI": [
                    "10.1177/26.12.366014"
                ]
            }
        },
        "BIBREF36": {
            "title": "Controlled Nucleation for the Regulation of the Particle Size in\nMonodisperse Gold Suspensions",
            "authors": [],
            "year": 1973,
            "venue": "Nature, Phys. Sci.",
            "volume": "241",
            "issn": "",
            "pages": "20-22",
            "other_ids": {
                "DOI": [
                    "10.1038/physci241020a0"
                ]
            }
        },
        "BIBREF37": {
            "title": "A hook effect-free immunochromatographic assay (HEF-ICA) for measuring the\nC-reactive protein concentration in one drop of human serum",
            "authors": [],
            "year": 2018,
            "venue": "Theranostics",
            "volume": "8",
            "issn": "",
            "pages": "3189-3197",
            "other_ids": {
                "DOI": [
                    "10.7150/thno.24034"
                ]
            }
        },
        "BIBREF38": {
            "title": "Temporal profiles of viral load in posterior oropharyngeal saliva samples\nand serum antibody responses during infection by SARS-CoV-2: an observational cohort\nstudy",
            "authors": [],
            "year": 2020,
            "venue": "Lancet Infect. Dis.",
            "volume": "20",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1016/S1473-3099(20)30196-1"
                ]
            }
        },
        "BIBREF39": {
            "title": "Molecular and serological investigation of 2019-nCoV infected patients:\nimplication of multiple shedding routes",
            "authors": [],
            "year": 2020,
            "venue": "Emerging Microbes Infect.",
            "volume": "9",
            "issn": "",
            "pages": "386-389",
            "other_ids": {
                "DOI": [
                    "10.1080/22221751.2020.1729071"
                ]
            }
        },
        "BIBREF40": {
            "title": "Preparation and characterization of Au colloid monolayers",
            "authors": [],
            "year": 1995,
            "venue": "Anal. Chem.",
            "volume": "67",
            "issn": "",
            "pages": "735-743",
            "other_ids": {
                "DOI": [
                    "10.1021/ac00100a008"
                ]
            }
        },
        "BIBREF41": {
            "title": "Preparation and evaluation of recombinant severe fever with\nthrombocytopenia syndrome virus nucleocapsid protein for detection of total antibodies\nin human and animal sera by double-antigen sandwich enzyme-linked immunosorbent\nassay",
            "authors": [],
            "year": 2012,
            "venue": "J. Clin. Microbiol.",
            "volume": "50",
            "issn": "",
            "pages": "372-377",
            "other_ids": {
                "DOI": [
                    "10.1128/jcm.01319-11"
                ]
            }
        },
        "BIBREF42": {
            "title": "Identification of a novel coronavirus in patients with severe acute\nrespiratory syndrome",
            "authors": [],
            "year": 2003,
            "venue": "N. Engl. J. Med.",
            "volume": "348",
            "issn": "",
            "pages": "1967-1976",
            "other_ids": {
                "DOI": [
                    "10.1056/nejmoa030747"
                ]
            }
        },
        "BIBREF43": {
            "title": "Newly discovered coronavirus as the primary cause of severe acute\nrespiratory syndrome",
            "authors": [],
            "year": 2003,
            "venue": "Lancet",
            "volume": "362",
            "issn": "",
            "pages": "263-270",
            "other_ids": {
                "DOI": [
                    "10.1016/s0140-6736(03)13967-0"
                ]
            }
        },
        "BIBREF44": {
            "title": "Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi\nArabia",
            "authors": [],
            "year": 2012,
            "venue": "N. Engl. J. Med.",
            "volume": "367",
            "issn": "",
            "pages": "1814-1820",
            "other_ids": {
                "DOI": [
                    "10.1056/nejmoa1211721"
                ]
            }
        },
        "BIBREF45": {
            "title": "Clinical features of patients infected with 2019 novel coronavirus in\nWuhan, China",
            "authors": [],
            "year": 2020,
            "venue": "Lancet",
            "volume": "395",
            "issn": "",
            "pages": "497-506",
            "other_ids": {
                "DOI": [
                    "10.1016/s0140-6736(20)30183-5"
                ]
            }
        },
        "BIBREF46": {
            "title": "Clinical Characteristics of Coronavirus Disease2019 in\nChina",
            "authors": [],
            "year": 2020,
            "venue": "N. Engl. J. Med.",
            "volume": "382",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1056/NEJMoa2002032"
                ]
            }
        }
    }
}